Extrahepatic manifestations of chronic hepatitis C

Chinese Journal of Digestive Diseases

Volumn 4, Issue 3, 2003, Pages 93-99

  Remoroza, Roderick ^a   Wu, George Y ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Arthritis; Cryoglobulinemia; Glomerulonephritis; Porphyria; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INTERFERON; RIBAVIRIN; STEROID;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CHRONIC HEPATITIS; CLINICAL FEATURE; CORNEA RODENT ULCER; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG CLEARANCE; HEPATITIS C; HUMAN; KERATOCONJUNCTIVITIS SICCA; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA HEMORRHAGE; RETINA ISCHEMIA; REVIEW; RHEUMATIC DISEASE; SJOEGREN SYNDROME; URTICARIA; VITILIGO;

EID: 0345327855     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9573.2003.00131.x     Document Type: Review

References (50)

1. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C. geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.
3. Brout JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am Med J 1974; 57: 775-88.
4. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4-13.
5. Casato M, Taliani G, Pucilo LP et al. Cryoglobulinemia and hepatitis C virus. Lancet 1991; 337: 1047-8.
6. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7.
7. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300.
8. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41.
9. Kallemuchikkal U, Gorevic PD. Evaluation of cryoglobulins. Arch Pathol Lab Med 1999; 123: 119-25.
10. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C virus infections in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-301.
11. Zuckerman E, Zuckerman T, Levine A, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-8.
12. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-45.
13. Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
14. Nouri K, Busso M, Machler BC. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C. Cutis 1997; 60: 289-90.
15. Simsek H, Savas C, Akkiz H, Telatar H. Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection. Dermatology 1996; 193: 65-7.
16. Mehta S, Levey JM, Bonkovsky HL. Extrahepatic manifestations of infection with hepatitis C virus. Clin Liver Dis 2001; 5: 979-1008.
17. Bulaj ZJ, Phillips JD, Ajioka RS et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-71.
18. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.
19. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994; 31: 100-2.
20. Gandolfo S, Carbone M, Carrozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection. is there a relationship? A report of 10 cases. J Oral Pathol Med 1994; 23: 119-22.
21. Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet 1995; 346: 1234.
22. Chosidow O, Lunel F, Fretz C, Szpirglas H, Frances C. Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol 1997; 133: 1052-3.
23. Ingafou M, Porter SR, Scully C, Teo CG. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 1998; 27: 65-6.
24. van der Meij EH, van der Waal I. Hepatitis C virus infection and oral lichen planus: a report from The Netherlands. J Oral Pathol Med 2000; 29: 255-8.
25. Nagao Y, Sata M, Abe K, Tanikawa K, Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 1997; 32: 324-9.
26. Pilli M, Penna A, Zerbini A et al. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology 2002; 36: 1446-52.
27. Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
28. Yamabe H, Johnson RJ, Gretch DR et al. Hepatitis C virus infection and membrano-proliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220-3.
29. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995; 44: 141-7.
30. Morales JM, Pascual-Capdevila J, Campistol JM et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63: 1634-9.
31. Usalan C, Erdem Y, Altun B et al. Rapidly progressive glomerulonephritis associated with hepatitis C virus infection. Clin Nephrol 1998; 49: 129-31.
32. Pucillo L, Agnello V, Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from virus-like particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994; 3: 465-70.
33. Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25: 1237-44.
34. Philipneri M, Bastani B. Kidney disease in patients with chronic hepatitis C. Curr Gastroenterol Rep 2001; 3: 79-83.
35. Poynard T, Cacoub P, Ratziu V et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002; 9: 295-303.
36. Buskila D, Schnaider A, Neumann L et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatits C virus infected Israeli patients. Semin Arthritis Rheum 1998; 28: 107-13.
37. Zuckerman E, Yeshurun D, Rosner I. Management of hepatitis C virus-related arthritis. Biodrugs 2001; 15: 573-84.
38. Kessel A, Rosner I, Zuckerman E, Golan TD, Toubi E. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. J Rheumatol 2000; 27: 610-12.
39. Zuckerman E, Keren D, Rozenbaum M et al. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol 2000; 18: 579-84.
40. Clifford BD, Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-19.
41. Cassani F, Cataleta M, Valentini P et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26: 561-6.
42. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sj gren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
43. Loustaud-Ratti V, Riche A, Liozon E et al. Prevalence and characteristics of Sjogren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2001; 28: 2245-51.
44. Guyer DR, Tiedeman J, Yannuzzi LA et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-6.
45. Abe T, Nakajima A, Satoh N et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol 1995; 39: 411.
46. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994 101: 736-45.
47. Zegans ME, Srinivasan M, McHugh T et al. Mooren ulcer in South India: serology and clinical risk factors. Am J Ophthalmol 1999; 128: 205-10.
48. Authier FJ, Pawlotsky JM, Viard JP, Guillevin L, Degos JD, Gherardi RK. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy. Ann Neurol 1993; 34: 749-50.
49. McKee DH, Young AC, Alonso-Dominguez A et al. Neurologic complications associated with hepatitis C virus infection. Neurology 2000; 55: 459.
50. Lacaille F, Zylberberg H, Hagege H et al. Hepatitis C associated with Guillain-Barre syndrome. Liver 1998; 18: 49-51.